These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 603518)

  • 1. Assessment of antithrombotic drugs ex vivo and in vivo.
    Buchanan M; Hirsh J
    Bibl Anat; 1977; (16 Pt 2):208-11. PubMed ID: 603518
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo.
    Buchanan MR; Hirsh J
    Thromb Res; 1978 Sep; 13(3):517-29. PubMed ID: 741444
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 4. Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium?
    Hladovec J
    Thromb Haemost; 1979 Jun; 41(4):474-8. PubMed ID: 483235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE; Bergqvist D; Tangen O
    Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
    Baumgartner HR
    Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo.
    Adams JH; Mitchell JR
    Thromb Haemost; 1979 Aug; 42(2):603-10. PubMed ID: 505367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of heparin, sulfinpyrazone and acetylsalicylic acid on the collagen-induced thromboyte aggregation].
    Haas S; Fritsche HM; Ketterl R; Leimgruber D; Blümel G
    Med Welt; 1979 Jun; 30(22):862-7. PubMed ID: 440074
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
    Buchanan M; Hirsh J
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
    Hanson SR; Harker LA; Bjornsson TD
    J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiaggregants of thrombocytes in ischemic heart disease].
    Beloev I ; Tomov I; TŭrnovskaR
    Vutr Boles; 1985; 24(5):1-6. PubMed ID: 2868572
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
    Hanson SR; Harker LA
    Ann N Y Acad Sci; 1983; 416():642-50. PubMed ID: 6587821
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic activity of glycosaminoglycans of mammalian origin. In vivo experiments in the rabbit.
    Niada R; Mantovani M; Pescador R
    Pharmacol Res Commun; 1979 Apr; 11(4):349-56. PubMed ID: 482321
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin and dipyridamole inhibition of collagen-induced platelet aggregation and release in cynomolgus monkeys.
    Wang ZG; McCann RL; Hagen PO
    Chin Med J (Engl); 1984 Jan; 97(1):19-23. PubMed ID: 6428828
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiplatelet therapy (first of two parts).
    Weiss HJ
    N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition of collagen-induced platelet aggregation and release function by aspirin and dipyridamole in cynomolgus monkey].
    Wang ZG
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Jun; 12(2):131-3. PubMed ID: 6489139
    [No Abstract]   [Full Text] [Related]  

  • 18. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit.
    Herbert JM; Dol F; Bernat A; Falotico R; Lalé A; Savi P
    Thromb Haemost; 1998 Sep; 80(3):512-8. PubMed ID: 9759636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of thrombus structure for the antithrombotic effectiveness of thrombocyte aggregation inhibiting substances and anticoagulants].
    Zimmermann R; Lange D; Zeltsch C; Barth P; Mörl H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1173-4. PubMed ID: 347772
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.